Internal Medicine, Pulmonary Disease · Seymour, IN
NPI
1770592727
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
225 S Pine St Ste 120
Seymour, IN, 47274
Phone (812) 524-3328
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
1,017 services
Medicare patients, 2024
337
Average age 73
Drug cost, 2024
$3.1M
4,220 prescriptions
Company payments, 2025
$49K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David S Wilson was code 99214 (office e&m - established), 255 times for 163 patients. In total David S Wilson billed 1,017 services in 27 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 255 | 163 | $90.15 | $23K |
| 99213 Office E&M - Established | Office | 181 | 136 | $62.96 | $11K |
| 94060 Pulmonary Function Testing | Facility | 110 | 110 | $7.37 | $811 |
| 94726 Pulmonary Function Testing | Facility | 99 | 99 | $8.48 | $839 |
| 94729 Pulmonary Function Testing | Facility | 98 | 98 | $6.36 | $624 |
| 94727 Pulmonary Function Testing | Facility | 96 | 96 | $8.66 | $831 |
| 99204 Office E&M - New | Office | 40 | 40 | $111.23 | $4,449 |
| 31624 Bronchoscopy | Facility | 28 | 25 | $11.93 | $334 |
| 99212 Office E&M - Established | Office | 23 | 21 | $39.16 | $901 |
| 31654 Bronchoscopy | Facility | 22 | 21 | $49.83 | $1,096 |
| 31628 Bronchoscopy | Facility | 22 | 21 | $113.16 | $2,490 |
By year: 2022 $67K for 1,271 services; 2023 $63K for 1,229 services; 2024 $51K for 1,017 services.
Medicare prescription drug claims, 2024
In 2024, the drug David S Wilson prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,034 prescriptions and refills. In total David S Wilson wrote 4,220 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,034 | 1,560 | 213 | $988K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 591 | 716 | 202 | $17K |
| Montelukast Sodium Generic | 492 | 1,068 | 141 | $3,110 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 449 | 509 | 133 | $321K |
| Prednisone Generic | 221 | 291 | 73 | $927 |
| Azithromycin Generic | 139 | 168 | 30 | $874 |
| Breo Ellipta Fluticasone/Vilanterol | 109 | 155 | 24 | $60K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 86 | 120 | 17 | $9,425 |
| Fasenra Pen Benralizumab | 83 | 144 | 15 | $496K |
| Roflumilast Generic | 83 | 119 | 15 | $2,990 |
| Azelastine Hcl Generic | 81 | 133 | 34 | $2,855 |
| Ventolin Hfa Albuterol Sulfate | 70 | 91 | 31 | $5,703 |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 55 | 77 | 12 | $38K |
| Spiriva Respimat Tiotropium Bromide | 47 | 73 | Under 11 | $38K |
| Pirfenidone Generic | 45 | 45 | Under 11 | $68K |
Brand drugs: 2,620 claims; generic drugs: 1,600 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David S Wilson $49K ($49K in general payments such as food, travel and fees) from 3 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $48K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.